Ultragenyx Pharmaceutical (RARE) Total Non-Current Liabilities (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) reported Total Non-Current Liabilities of $429 million for Q2 2026, up 15.2% from $372.52 million a year earlier and up 6.2% from the prior quarter.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends
At the end of FY2025, Ultragenyx Pharmaceutical posted Total Non-Current Liabilities of $465 million, up 8.6% from FY2024.
- Total Non-Current Liabilities has increased for four consecutive years, with a five-year compound annual growth rate of 11.5% (FY2020 to FY2025).
- By year, Total Non-Current Liabilities came in at $428 million in FY2024 (+21.0%), $353.69 million in FY2023 (+11.2%), $318.01 million in FY2022 (+28.2%) and $248.05 million in FY2021 (-8.0%).
- Five-year quarterly Total Non-Current Liabilities spans a low of $203.05 million in Q3 2021 and a high of $465 million in Q4 2025.
- Year over year, Total Non-Current Liabilities has now increased in each of the last 18 quarters, with growth averaging 13.0% over the last eight quarters.
- The high point for year-over-year Total Non-Current Liabilities in five years was Q2 2022 (growth of 44.5%); the low point was Q3 2021 (a decline of 25.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $404 million (Q1 2026), $465 million (Q4 2025) and $417.55 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Ultragenyx Pharmaceutical | 1.62 Bn | -186.47 Mn | 180.00 Mn | 388.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 388.00 Mn |
| Mar 31, 2026 | 362.00 Mn |
| Dec 31, 2025 | 421.00 Mn |
| Sep 30, 2025 | 398.77 Mn |
| Jun 30, 2025 | 355.12 Mn |
| Mar 31, 2025 | 356.76 Mn |
| Dec 31, 2024 | 411.00 Mn |
| Sep 30, 2024 | 345.72 Mn |
| Jun 30, 2024 | 328.67 Mn |
| Mar 31, 2024 | 303.61 Mn |
| Dec 31, 2023 | 341.48 Mn |
| Sep 30, 2023 | 320.20 Mn |
| Jun 30, 2023 | 290.89 Mn |
| Mar 31, 2023 | 267.19 Mn |
| Dec 31, 2022 | 313.19 Mn |
| Sep 30, 2022 | 283.53 Mn |
| Jun 30, 2022 | 279.84 Mn |
| Mar 31, 2022 | 228.58 Mn |
| Dec 31, 2021 | 247.05 Mn |
| Sep 30, 2021 | 202.58 Mn |
API Access
Ultragenyx Pharmaceutical Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();